Antioxidant effect of angiotensin (1‑7) in the protection of pancreatic β cell function
- PMID: 27430410
- PMCID: PMC4991744
- DOI: 10.3892/mmr.2016.5514
Antioxidant effect of angiotensin (1‑7) in the protection of pancreatic β cell function
Abstract
It is well known that the local renin-angiotensin system (RAS) is activated in the diabetic state, which results in an increase in the level of oxidative stress injury to pancreatic β cells. The angiotensin‑converting enzyme 2 (ACE2)/angiotensin (1‑7) [Ang (1‑7)]/Mas axis is a negative regulator of the classical renin‑angiotensin system. In order to investigate the antioxidant effect of Ang (1‑7) on pancreatic β cells, INS‑1 cells were cultured and oxidative stress was induced by treatment with H2O2. Glucose‑stimulated insulin secretion (GSIS), the generation of reactive oxygen species (ROS), mitochondrial membrane potential (MMP) and glucose-stimulated calcium (GSCa) responses in β cells were determined following treatment with Ang (1-7). It was observed that H2O2 significantly impaired the insulin secreting function, increased the production of ROS, and also decreased the levels of GSCa and MMP. Pre‑treatment with Ang (1‑7) alleviated these effects and treatment with A779 [antagonist of Ang (1‑7)] prevented the effects of Ang (1-7). Based on these findings, it was concluded that Ang (1‑7) can protect pancreatic β cells from oxidative injury and such protection can be blocked by its antagonist A779.
Figures





Similar articles
-
The ACE2/Ang-(1-7)/Mas Axis Regulates the Development of Pancreatic Endocrine Cells in Mouse Embryos.PLoS One. 2015 Jun 1;10(6):e0128216. doi: 10.1371/journal.pone.0128216. eCollection 2015. PLoS One. 2015. PMID: 26029927 Free PMC article.
-
The Angiotensin-(1-7)/Mas Axis Improves Pancreatic β-Cell Function in Vitro and in Vivo.Endocrinology. 2016 Dec;157(12):4677-4690. doi: 10.1210/en.2016-1247. Epub 2016 Oct 7. Endocrinology. 2016. PMID: 27715254
-
Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes.Acta Diabetol. 2012 Aug;49(4):291-9. doi: 10.1007/s00592-011-0348-z. Epub 2011 Nov 1. Acta Diabetol. 2012. PMID: 22042130
-
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.Mol Cell Endocrinol. 2013 Sep 25;378(1-2):15-22. doi: 10.1016/j.mce.2012.04.011. Epub 2012 May 4. Mol Cell Endocrinol. 2013. PMID: 22564510 Review.
-
Reactive oxygen species and uncoupling protein 2 in pancreatic β-cell function.Diabetes Obes Metab. 2010 Oct;12 Suppl 2:141-8. doi: 10.1111/j.1463-1326.2010.01269.x. Diabetes Obes Metab. 2010. PMID: 21029311 Review.
Cited by
-
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies.Cancer Cell Int. 2023 Oct 27;23(1):254. doi: 10.1186/s12935-023-03080-9. Cancer Cell Int. 2023. PMID: 37891636 Free PMC article. Review.
-
ACE2 pathway regulates thermogenesis and energy metabolism.Elife. 2022 Jan 11;11:e72266. doi: 10.7554/eLife.72266. Elife. 2022. PMID: 35014608 Free PMC article.
-
Untargeted metabolomics uncovers metabolic dysregulation and tissue sensitivity in ACE2 knockout mice.Heliyon. 2024 Mar 8;10(6):e27472. doi: 10.1016/j.heliyon.2024.e27472. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38496880 Free PMC article.
-
Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes.Int J Mol Sci. 2022 May 15;23(10):5522. doi: 10.3390/ijms23105522. Int J Mol Sci. 2022. PMID: 35628332 Free PMC article. Review.
-
Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade.World J Hepatol. 2017 Jan 18;9(2):74-79. doi: 10.4254/wjh.v9.i2.74. World J Hepatol. 2017. PMID: 28144388 Free PMC article.
References
-
- Nakayama M, Inoguchi T, Sonta T, Maeda Y, Sasaki S, Sawada F, Tsubouchi H, Sonoda N, Kobayashi K, Sumimoto H, Nawata H. Increased expression of NAD (P)H oxidase in islets of animal models of Type 2 diabetes and its improvement by an AT1 receptor antagonist. Biochem Biophys Res Commun. 2005;332:927–933. doi: 10.1016/j.bbrc.2005.05.065. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous